
424.55MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US29251M1062
CUSIP
29251M106
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
September
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
4.36
Dividend Share
-
Dividend Yield
-
Earnings Share
-3.19
Wall Street Target Price
18.50
EPS Estimate Current Year
-2.13
EPS Estimate Next Year
-2.21
EPS Estimate Current Quarter
-0.876
EPS Estimate Next Quarter
-0.81
Most Recent Quarter
-
Revenue TTM
66,980,000
Gross Profit TTM
66,980,000
EBITDA
-68,132,000
Profit Margin
-106.80%
Return On Assets TTM
-13.47%
Return On Equity TTM
-60.01%
Revenue Per Share TTM
2.885
Qtly Revenue Growth YOY
9.80%
Diluted Eps TTM
-3.19
Qtly Earnings Growth YOY
-66.20%
Trailing PE
0.00
Forward PE
44
Price Sales TTM
6.3038
Price Book MRQ
3.3285
Enterprise Value Revenue
4
Enterprise Value EBITDA
41
25.46
2.83%320.68
0.17%712.02
0.00%96.69
-4.43%320.24
-3.90%432.35
-2.07%328.30
-1.73%827.25
-1.70%156.87
-1.61%743.00
-1.42%